Abstract
Digital self-guided mobile health (mHealth) applications are cost-effective, accessible, and well-suited to improve mental health at scale. This randomized controlled trial (RCT) evaluated the effectiveness of a recently developed mHealth programme based on cognitive-behavioral therapy (CBT) principles in improving worry. We also examined psychological mindedness (PM) as a mediator by which app engagement is thought to improve outcomes. The intervention group completed a 2-week “Anxiety and Worry” programme with daily CBT-informed activities, while the active waitlist-control completed a matched 2-week mHealth programme on procrastination. Participants filled out the Generalized Anxiety Disorder (GAD-7), Patient Health Questionnaire (PHQ-9), and Psychological Mindedness Scale (PMS) at baseline, post-intervention and 2-week follow-up. App engagement was measured at post-intervention only. Both groups showed significant improvements on anxiety and depression scores from baseline to post-intervention, but no group differences were observed. From post-intervention to follow-up, only the intervention group showed further improvements for anxiety levels. Higher engagement with the mHealth app reported lower anxiety at post-intervention, and this relationship was fully mediated by psychological mindedness. This study provides evidence that (a) engaging in a CBT mHealth App can effectively reduce anxiety and worry, and (b) Psychological mindedness is a potential pathway by which engaging with a mHealthapp improves worry. While overall effect sizes were small, at the population level, these can make significant contributions to public mental health.
Author Summary Increasing burden of anxiety amongst young adults has made widely accessible mobile health applications a promising tool in improving anxiety levels at scale. We conducted a randomized controlled trial (N=309) to examine the effectiveness of a brief, publicly available mobile health application (Intellect’s “Anxiety and Worry” programme) in reducing anxiety and worry levels among young adults. Participants who received the intervention showed significant reduction in anxiety and depression levels, however, effects did not significantly differ from active control. At post-intervention, only the intervention group continued to experience improvements in anxiety level. We also found that higher app engagement with the mHealth app predicted better anxiety and depression outcomes, and this relationship was fully mediated by psychological mindedness. Future work would benefit from inclusion of waitlist control, a larger sample size, and identification of alternative mediators.
Competing Interest Statement
Dr. Suendermann set up the RCA between NUS and Intellect in 2020, and in January 2022 joined Intellect Pte Ltd. as their Clinical Director. Feodora Roxanne Kosasih and Sean Han Yang Toh are employed as research associates at Intellect. The study design, data management, interpretation, analysis, reporting, and decision to publish of the study are entirely independent of Intellect Pte Ltd.
Clinical Trial
NCT04911803
Funding Statement
The study was partly funded by Intellect Co Pte Ltd under a Research Collaboration Agreement (RCA) with the National University of Singapore (NUS).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
National University of Singapore Institutional Review Board (NUS-IRB Reference Code: 2021-266)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Data Availability
The data that support the findings of this study are available on request from the corresponding author (OS).
